Comparison of Efficacy and Tolerability of Aceclofenac and Diclofenac in Osteoarthritis of Knee Joint


Arshiya Sehgal
Vijay Kumar Sehgal
Ravinder Singh


Background: Osteoarthritis is a slowly progressive disorder associated with a hyaline cartilage loss. Non-steroidal anti-inflammatory drugs play a pertinent role in management of osteoarthritis.Objectives: The study was carried out for the comparison of efficacy and tolerability of Aceclofenac and Diclofenac in patients of osteoarthritis of knee joint.Material and Methods: It is a randomised parallel group double blinded study. The study included 60 patients of confirmed osteoarthritis of knee joint, 30 patients were given Aceclofenac and 30 patients were given Diclofenac after food for 8 weeks and the patients were evaluated and compared statistically for pain intensity by VAS Score, Joint tenderness, Swelling, Erythema, Pain on movement, Functional capacity and Overall Assessment on LIKERT Scale.Results: Both the drugs caused marked improvements in the parameters of - Pain intensity, Joint tenderness, Swelling, Erythema, Pain on movement of OA knee joint but there was increased improvement in all the parameters with aceclofenac. Conclusion: Aceclofenac is the NSAID of choice in the osteoarthritis of knee joint as compare to Diclofenac.


How to Cite
Sehgal, A., Sehgal, V. K., & Singh, R. (2015). Comparison of Efficacy and Tolerability of Aceclofenac and Diclofenac in Osteoarthritis of Knee Joint. International Journal of Medical and Dental Sciences, 745–750.


  1. Brandt KD. Osteoarthritis. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL editors. Harrison’s Principles of Internal Medicine. 16th ed. New YORK: Mc Graw-HILL;2005.p.2036-2045.
  2. Anderson JJ, Felson DT. Factors associated with osteoarthritis of the knee in the first National Health and Nutrition Examination Survey (HANES I). Evidence for an association with overweight, race and physical demands of work. Am J Epidemiol 1988;128:179-89.
  3. Brandt KD, Radin EL, Dieppe PA, Van de Putte L. Yet more evidence that osteoarthritis is not a cartilage disease. Ann Rheum Dis 2006;65(10):1261–1264.
  4. Bedson J, Jordan K, Croft P. The prevalence and history of knee osteoarthritis in general practice: a case control study. Fam Pract 2005;22:103-108.
  5. Felson DT, Zhang Y, Anthony JM, Naimark A, Anderson JJ. Weight loss reduces the risk of symptomatic knee osteoarthritis in women: The Framingham Study. Ann Intern Med 1992; 116:535-39.
  6. Felson DT, Anderson J, Naimark A. Obesity and knee Osteoarthritis: The Farmigham Study. Ann Int Med 1991;18:109.
  7. Felson DT, Zhang Y, Hannan MT, Naimark A, Weissman BN, Aliabadi P, et al. The incidence and natural history of knee osteoarthritis in the elderly. The Framingham osteoarthritis Study. Arthritis Rheum 1995;38:1500-1505.
  8. Blobaum AL, Marnett LJ. Molecular determinants for the selective inhibition of cyclo-oxygenase-2 by lumiracoxib. J Biol Chem 2007;282:16379–90.
  9. Burian M, Tegeder I, Seegel M, Geisslinger G. Peripheral and central antihyperalgesic effects of diclofenac in a model of human inflammatory pain. Clin Pharmacol Ther 2003;74:113–20.
  10. Dooley M, Spencer CM, Dunn CJ. Aceclofenac. A Reappraisal of its use in the management of pain and rheumatic disease. Drugs 2001;61(9):1351-78.
  11. Reginster JY, Paul L, Henrotin Y. What is the role of aceclofenac in the therapeutic arsenal against chronic osteoarthritis pathologies? Rev Med Liege 2001 Jul;56(7):484-8.
  12. Hart DJ, Spector TD. Radiographic criteria for epidemiological studies of osteo arthriti rheumatol 1995;22(43):46-48.
  13. Burke A, Smyth E, Fitzgerald GA. Analgesics – Antipyretic agents, Pharmacotherapy of gout. In: Brunton LC, Lazo JS, Parker KL editors. Goodman and Gilman’s pharmacological basis of therapeutics. 11th edn. New York: McGraw Hill; 2006.p.671-715.
  14. Hochberg MC. Osteoarthritis: Clinical features and treatment. In: Hochberg MC, editor. Primer on the Rheumatic diseases. 11th edn. Atlanta: Arthritis Foundation; 1997.p.218- 221.
  15. Ward DE, Veys EM, Bowdler JM. Comparison of aceclofenac with diclofenac in the treatment of osteoarthritis. Clin Rheumatol 1995 Nov;14:656-62.
  16. Kornasoff D, Frerick H, Bowdler J, Montull E. Aceclofenac is a well tolerated alternative to Naproxen in the treatment of osteoarthritis. Clin Rheumatol 1997 Jan;16(1):32-8.
  17. Diaz C, Rodriguez de la Serna A, Geli C, Belmonte MA, Olmedo J, Bltran J. Efficacy and tolerability of aceclofenac versus diclofenac in the treatment of knee arthritis: a multicentre study. Eur J Rheumatol Inflamm 1996;16(1):17-22.
  18. Gualda EB, Ivorra JR, Mola EM, Abello JC, Ferrando LFL, Molina JT, et al. Aceclofenac vs paracetamol in the management of symptomatic osteoarthritis of the knee: a double blind 6 week randomized controlled trial. Osteoarthritis and cartilage 2007;15(8):900-908.

Most read articles by the same author(s)

1 2 > >>